# Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)

> **NCT03768765** · — · TERMINATED · sponsor: **University of Kansas Medical Center** · enrollment: 144 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **PROCEDURE:** Holmium Laser Prostate Surgery

## Key facts

- **NCT ID:** NCT03768765
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-15
- **Primary completion:** 2024-06-19
- **Final completion:** 2024-08-27
- **Target enrollment:** 144 (ACTUAL)
- **Why stopped:** Slow recruitment of patients who have been on medication for under a year for benign prostatic hyperplasia
- **Last updated:** 2024-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03768765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03768765, "Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03768765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*